{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:26:29Z","timestamp":1792009589514,"version":"4.4.0"},"reference-count":22,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.5551\/jat.63460","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T22:10:01Z","timestamp":1647641401000},"page":"138-149","source":"Crossref","is-referenced-by-count":16,"title":["Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-\u03baB Signaling Pathway"],"prefix":"10.5551","volume":"30","author":[{"given":"Li-wei","family":"Guo","sequence":"first","affiliation":[{"name":"School of Forensic Medicine, Xinxiang Medical University"},{"name":"Xinxiang Key Laboratory of Metabolism and Integrative Physiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-kai","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Xinxiang Medical University"},{"name":"Xinxiang Key Laboratory of Metabolism and Integrative Physiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-jie","family":"Li","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Xinxiang Medical University"},{"name":"Xinxiang Key Laboratory of Metabolism and Integrative Physiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-tian","family":"Yin","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Xinxiang Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Li","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Xinxiang Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, Nishigaki I: The vascular endothelium and human diseases. Int J Biol Sci, 2013; 9: 1057-1069","DOI":"10.7150\/ijbs.7502"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Godo S, Shimokawa H: Endothelial functions. Arterioscler Thromb Vasc Biol, 2017; 37: e108-e114","DOI":"10.1161\/ATVBAHA.117.309813"},{"key":"3","unstructured":"3) Gohil A, Imel EA: FGF23 and associated disorders of phosphate wasting. Pediatr Endocrinol Rev, 2019; 17: 17-34"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Rodr\u00edguez M: FGF23: Is it another biomarker for Phosphate-Calcium metabolism? Adv Ther, 2020; 37: 73-79","DOI":"10.1007\/s12325-019-01181-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lu X, Hu MC: Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease. Kidney Dis (Basel), 2017; 3: 15-23","DOI":"10.1159\/000452880"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Chou F, Chen J, Huang S, Chan Y, Chi S, Chen W: Changes in serum FGF23 and Klotho levels and calcification scores of the abdominal aorta after parathyroidectomy for secondary hyperparathyroidism. Am J Surg, 2019; 218: 609-612","DOI":"10.1016\/j.amjsurg.2018.12.026"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Six I, Okazaki H, Gross P, Cagnard J, Boudot C, Maizel J, Drueke T B, Massy ZA: Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium. PLoS One, 2014; 9: e93423","DOI":"10.1371\/journal.pone.0093423"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Silswal N, Touchberry CD, Daniel DR, McCarthy DL, Zhang S, Andresen J, Stubbs JR, Wacker MJ: FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am J Physiol Endocrinol Metab, 2014; 307: E426-436","DOI":"10.1152\/ajpendo.00264.2014"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Lindberg K, Olauson H, Amin R, Ponnusamy A, Goetz R, Taylor RF, Mohammadi M, Canfield A, Kublickiene K, Larsson TE: Arterial Klotho expression and FGF23 effects on vascular calcification and function. PLoS One, 2013; 8: e60658","DOI":"10.1371\/journal.pone.0060658"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Richter B, Haller J, Haffner D, Leifheit-Nestler M: Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells. Pflugers Arch, 2016; 468: 1621-1635","DOI":"10.1007\/s00424-016-1858-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R: Guidelines for the ultrasound assessment of endothelial dependent flow mediated vosodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol, 2002; 39: 2572265","DOI":"10.1016\/S0735-1097(01)01746-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Jimbo R, Shimosawa T: Cardiovascular risk factors and chronic kidney disease-FGF23: a key molecule in the cardiovascular disease. Int J Hypertens, 2014; 2014: 381082","DOI":"10.1155\/2014\/381082"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, Landray MJ, Moe SM, Yang J, Holland L, Giuseppe R, Krijger AB, Mihaylova B, Herrington WG: Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis. J Am Soc Nephrol, 2018; 29: 2015-2027","DOI":"10.1681\/ASN.2017121334"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mirza M AI, Larsson A, Lind L, Larsson TE: Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis, 2009; 205: 385-390","DOI":"10.1016\/j.atherosclerosis.2009.01.001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Taylor EN, Rimm EB, Stampfer MJ, Curhan GC: Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J, 2011; 161: 956-962","DOI":"10.1016\/j.ahj.2011.02.012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Soares RN, Somani YB, Proctor DN, Murias JM: The association between near-infrared spectroscopy-derived and flow-mediated dilation assessment of vascular responsiveness in the arm. Microvasc Res, 2019; 122: 41-44","DOI":"10.1016\/j.mvr.2018.11.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Tremblay JC, Pyke KE: Flow-mediated dilation stimulated by sustained increases in shear stress: a useful tool for assessing endothelial function in humans? Am J Physiol Heart Circ Physiol, 2018; 314: H508-H520","DOI":"10.1152\/ajpheart.00534.2017"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Roumeliotis S, Mallamaci F, Zoccali C: Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update. J Clin Med, 2020; 9: 2359","DOI":"10.3390\/jcm9082359"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Verkaik M, Juni RP, van Loon E PM, van Poelgeest EM, Kwekkeboom Rick F J, Gam Z, Richards WG, Wee P M Ter, Hoenderop JG, Eringa EC, Vervloet MG: FGF23 impairs peripheral microvascular function in renal failure. Am J Physiol Heart Circ Physiol, 2018; 315: H1414-H1424","DOI":"10.1152\/ajpheart.00272.2018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sarmento-Dias M, Santos-Ara\u00fajo C, Po\u00ednhos R, Oliveira B, Silva IS, Silva LS, Sousa MJ, Correia F, Pestana M: Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients. Clin Nephrol, 2016; 85: 135-141","DOI":"10.5414\/CN108716"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) D\u2019Arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C: FGF23 and the PTH response to paricalcitol in chronic kidney disease. Eur J Clin Invest, 2020; 50: e13196","DOI":"10.1111\/eci.13196"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Karunakaran D, Nguyen MA, Geoffrion M, Vreeken D, Lister Z, Cheng HS, Otte N, Essebier P, Wyatt H, Kandiah JW, Jung R, Alenghat FJ, Mompeon A, Lee R, Pan C, Gordon E, Rasheed A, Lusis AJ, Liu P, Matic LP, Hedin U, Fish JE, Guo L, Kolodgie F, Virmani R, van Gils JM, Rayner KJ: RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-kappaB Activation and Atherogenesis in Mice. Circulation, 2021; 143: 163-177","DOI":"10.1161\/CIRCULATIONAHA.118.038379"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/2\/30_63460\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:49:31Z","timestamp":1715316571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/2\/30_63460\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63460","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"article-number":"63460"}}